Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database.
Zuzana ŠpacírováDavid M EpsteinJaime EspínPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Analysts should evaluate carefully whether DRG costs or tariffs published in each country are appropriate for use in economic evaluation.